StockNews.com began coverage on shares of Ampio Pharmaceuticals (NYSE:AMPE – Free Report) in a report released on Friday morning. The brokerage issued a sell rating on the stock.
Ampio Pharmaceuticals Stock Performance
NYSE:AMPE opened at $0.00 on Friday. Ampio Pharmaceuticals has a 12-month low of $0.00 and a 12-month high of $7.47. The firm has a market cap of $2,497.00, a price-to-earnings ratio of 0.00 and a beta of 3.67. The company’s 50-day moving average is $0.01 and its two-hundred day moving average is $0.36.
Ampio Pharmaceuticals Company Profile
Further Reading
- Five stocks we like better than Ampio Pharmaceuticals
- How is Compound Interest Calculated?
- Analysts Predict 85% Upside for Wave Life Sciences After Rate Cut
- What Does Downgrade Mean in Investing?
- FedEx Stock Dips: Another Reason to Fear Recession Is Near
- ESG Stocks, What Investors Should Know
- The Half-Penny Revolution: Will SEC’s Reform Benefit Investors?
Receive News & Ratings for Ampio Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ampio Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.